We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
53 hedge funds and large institutions have $16.1M invested in Anavex Life Sciences in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
120% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 10
15% more funds holding
Funds holding: 46 → 53 (+7)
31% less capital invested
Capital invested by funds: $23.4M → $16.1M (-$7.23M)
77% less call options, than puts
Call options by funds: $332K | Put options by funds: $1.46M
Holders
53
Holders Change
+7
Holders Change %
+15.22%
% of All Funds
1.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
22
Reduced
10
Closed
4
Calls
$332K
Puts
$1.46M
Net Calls
-$1.12M
Net Calls Change
-$824K
Top Buyers
| 1 |
Northern Trust
Chicago,
Illinois
|
+$1.05M |
| 2 |
State Street
Boston,
Massachusetts
|
+$919K |
| 3 |
D.E. Shaw & Co
New York
|
+$442K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$432K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$154K |
